All these results indicate that Gal-1, both endogenously and exogenously – deriving from tumor cells, the tumor stroma, or tumor-infiltrating immune cell populations – supports cancer cell development and modulates the anti-tumor immune defense in several ways. Here, LGALS1 is linked to neoplasm.